MDHearing Neo XS vs Resound Vivia 9 60S microRIE

The MDHearing Neo XS is a budget-priced OTC hearing aid in the invisible-in-ear style, available for $397. In HearAdvisor lab testing, it earned a C grade with a SoundScore of 2.9/5, ranking #63 of 65 OTC hearing aids tested. Performance results reveal a mixed profile. The Neo XS shows strength in own-voice comfort, scoring 3.2/5—0.69 points above the category average—meaning wearers may experience less of the "boomy" quality that can accompany hearing aid use. Feedback handling is excellent at 5.0/5, sitting 0.46 points above average, so users should experience stable performance without whistling during typical wear. However, speech clarity is a significant limitation. Speech in quiet scores just 1.0/5, falling 1.77 points below the OTC category average. Speech in noise also scores 1.0/5, 0.48 points below average. Music streaming scored 0.0/5, which is 1.92 points below the category average—this device is not suited for audio entertainment. At this price point, several alternatives offer notably stronger performance. The Elehear Beyond (4.36/5), Apple AirPods Pro 2 (4.06/5), and Zepp Clarity Omni (3.88/5) all deliver better overall sound quality in the same price range. The Neo XS may appeal to those prioritizing own-voice comfort and feedback stability over speech intelligibility, but most users seeking meaningful hearing benefit should consider higher-scoring options.

The Resound Vivia 9 60S microRIE is a premium prescription behind-the-ear hearing aid released in 2025, currently available at $3,798. In HearAdvisor's lab testing, it earned a B grade with a SoundScore of 3.9/5, ranking #27 of 36 prescription hearing aids tested. This device demonstrates a mixed performance profile in our testing. Own-voice comfort is a notable strength, scoring 3.4/5—a solid result that sits 0.65 points above the category average, which may appeal to users sensitive to the hollow or boomy sound of their own speech. Speech clarity in quiet environments also performs well at 3.4/5, slightly above the category average. However, the Vivia 9 shows significant limitations in challenging listening situations. Speech in noise scored just 1.1/5, falling 0.81 points below the prescription hearing aid average—a substantial gap that suggests difficulty in restaurants, group conversations, or other noisy environments. Feedback handling, while strong in absolute terms at 4.2/5, still lands 0.51 points below what we typically see from prescription devices. Music streaming quality is mixed at 2.6/5, essentially matching the category average. At this premium price point, the Vivia 9 faces stiff competition. Several same-priced alternatives, including the Phonak Sphere Infinio and Oticon Intent, achieved notably higher overall scores in our testing. Consumers prioritizing noise performance may want to explore these options or consider lower-priced alternatives like the Sennheiser All Day Clear that delivered stronger overall results in our lab.